IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Login 
Users Online : 1477 
Small font sizeDefault font sizeIncrease font size
Navigate Here
  »   My Preferences 
  »   Manuscript submission

 


This article has been cited by
1Etizolam withdrawal catatonia: The first case report
Debanjan Banerjee
Asian Journal of Psychiatry.2018;37()32
[DOI]
2An expanding world of new psychoactive substances—designer benzodiazepines
Jolanta B. Zawilska,Jakub Wojcieszak
NeuroToxicology.2019;73()8
[DOI]
3Les « designer benzodiazepines » : qu’en sait-on aujourd’hui ?
Emil Chetraru,Alice Ameline,Laurie Gheddar,Jean-Sébastien Raul,Pascal Kintz
Toxicologie Analytique et Clinique.2018;30(1)5
[DOI]
4Novel Ways to Acquire Designer Benzodiazepines: A Case Report and Discussion of the Changing Role of the Internet
Anna P. Shapiro,Travis S. Krew,Mohsen Vazirian,Jason Jerry,Christopher Sola
Psychosomatics.2019;60(6)625
[DOI]
5Is etizolam a safe medication? Effects on psychomotor perfomance at therapeutic dosages of a newly abused psychoactive substance
Francesco Paolo Busardò,Annagiulia Di Trana,Eva Montanari,Simona Mauloni,Adriano Tagliabracci,Raffaele Giorgetti
Forensic Science International.2019;301(6)137
[DOI]
6Organ distribution of diclazepam, pyrazolam and 3-fluorophenmetrazine
Sabrina Lehmann,Alissa Sczyslo,Judith Froch-Cortis,Markus Alexander Rothschild,Mario Thevis,Hilke Andresen-Streichert,Katja Mercer-Chalmers-Bender
Forensic Science International.2019;303(6)109959
[DOI]
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow